The role of lung transplantation: When and for whom

Seminars in Respiratory and Critical Care Medicine

Volumn 17, Issue 6, 1996, Pages 517-531

  Yu, Nelson C ^a   Bjorn, Paul A ^a   Maurer, Janet R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; HUMAN; LUNG FIBROSIS; LUNG TRANSPLANTATION; PATIENT SELECTION; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME;

EID: 0030477204     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009928     Document Type: Conference Paper

References (101)

1. The Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140-5
2. Theodore J, Lewiston N Lung transplantation comes of age. N Engl J Med 1990;322:772-4
3. Official ATS Statement - June 1992. Lung transplantation: report of the ATS workshop on lung transplantation. Am Rev Respir Dis 1993;147:772-6
4. Egan TM, Kaiser LE, Cooper JD. Lung transplantation. Curr Prob Surg 1989;26:673-752
5. Langer M, Mosconi P, Cigada M, et al. Long-term respiratory support and risk of pneumonia in critically ill patients. Am Rev Respir Dis 1989;140:302-3
6. End A, Grimm M, Mares P, et al. Successful lung transplantation in a long-term ventilator-dependent patient. Ann Thorac Surg 1993;56 562-4
7. Low DE, Trulock EP, Kayser LR, et al. Lung transplantation of ventilator-dependent patients. Chest 1992;101:8-11
8. Flume PA, Egan TM, Westerman JH, et al. Lung transplantation for mechanically ventilated patients. J Heart Lung Transplant 1994;13 15-21
9. Myers BD, Ross J, Newton L, et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984;311:699-705
10. Harjula ALJ, Baldwin JC, Oyer PE, et al. Recipient selection for heart-lung transplantation. Scand J Thor Cardiovasc Surg 1988;22:193-6
11. Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol 1996;27:384-91
12. Pasque MK, Trulock EP, Cooper JD, et al. Single lung transplantation for pulmonary hypertension. Circulation 1995,92:2252-8
13. Ritchie M, Waggoner AD, Davila-Ramon VG, et al. Echocardiographic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. J Am Coll Cardiol 1993;22:1170-4
14. Thaik CM, Semigran MJ, Ginns L, et al. Evaluation of ischemic heart disease in potential lung transplant recipients. J Heart Lung Transplant 1995;14:257-66
15. Mai FM, McKenzie FN, Kostuk WJ. Psychiatric aspects of heart transplantation: preoperative evaluation and postoperative sequelae. Br Med J 1986;292:311-3
16. Goldberg M, Lima O, Morgan E, et al. A comparison be-tween cyclosporin A and methylprednisolone plus azathioprine on bionchial healing following canine lung autotransplantation. J Thorac Cardiovasc. Surg 1983;85: 821-6
17. Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Clin Chest Med 1991;11:555-69
18. St. Louis International Lung Transplant Registry. Washington University. St. Louis, Missouri. April 1996 Report.
19. King MB, Campbell EJ, Grav BH, et al. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients Am J Respir Crit Care Med 1994;149:966-71
20. Kern JA, Fishman AP. End stage fibrotic lung disease: treatment and prognosis. In: Fishman AP, ed. Pulmonary Diseases and Disorders. 2nd ed. McGraw-Hill, New York, 1988;2237-50
21. Hayden A, Robert R, Kriett J, et al. Primary diagnosis predicts prognosis of lung transplant candidates. Transplantation 1993;55:1048-50
22. Rich S. Primary pulinonary hypertension. Prog Cardiovasc Dis 1988;31:205-38
23. Fuster V, Steele PM, Edwards WD, et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70:580-85
24. Ackerman DM, Edwards WD. Sudden death as the initial manifestation of primary pulmonary hypertension. Am J Forensic Med Pathol 1987;8:97-102
25. Kramer MR, Marshall SE, Tiroke A, et al. Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation. J Heart Lung Transplant 1991;10:317-21
26. D'Alonzo GE, Barst RJ, Avers SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;113: 343-9
27. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-23
28. Hopkins WE, Ochoa LL, Richardson GW, et al. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996;15:100-5
29. Scanlin TF Cystic fibrosis. In: Fishman AP, ed. Pulmonary Diseases and Disorders. 2nd ed. McGraw-Hill, New York, 1988;1273-94
30. Starnes VA, Lewiston N, Theodore J, et al. Cystic fibrosis. Target population for lung transplantation in North America in the 1990s. J Thorac Cardiovasc Surg 1992; 103:1008-14
31. Nixon PA, Orenstein DM, Kelsev SF, et al. The prognostic value of exercise testing in patient with cystic fibrosis. N Engl J Med 1992;327:1785-8
32. Umetsu DT, Moss RB, King VV, et al. Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbations. Lancet 1990;335:1077-8
33. Lewiston N, King V, Umetsu D, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991;23:1207-8
34. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-64
35. Stevens PM, Johnson PC, Bell RL, et al. Regional ventilation and perfusion after lung transplantation in patients with emphysema. N Engl J Med 1970;282:245-9
36. Trulock EP, Egan TM, Kouchoukos NT, et al Single lung transplantation for severe chronic obstructive pulmonary disease. Chest 1989;96:738-42
37. Patterson G, Maurer, Williams T, et al. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. J Thorac Cardiovasc Surg 1991; 101:623-32
38. Mal H, Andreasstan B, Pamela F, et al. Unilateral lung transplantation in end-stage pulmonary emphysema. Am Rev Respir Dis 1989;140:797-802
39. Grossman RF, Frost A, Zamel M, et al. Results of single lung transplantation for bilateral pulmonary fibrosis. N Engl J Med 1990;322:727-33
40. Frost AE, Keller CA, Noon GP, et al. Outcome of the native lung after single lung transplant. Chest 1995;107:981-4
41. Maurer J, Winton T, Patterson G, et al. Single-lung transplantation for pulmonary vascular disease. Transplant Proc 1991;23:1211-2
42. McCarthy PM, Rosenkranz ER, White RD, et al. Single-lung transplantation with atrial septal detect repair for Eisenmenger's syndrome. Ann Thorac Surg 1991;52:300-3
43. Starnes VA, Lewiston NJ, Luikart H, et al. Current trends in lung transplantation: lobar transplantation and expanded use of single lungs. J Thorac Cardiovasc Surg 1992;104: 1060-6
44. Barbers RG, Chan KM, Barr ML, et al. Bilateral lobar lung transplantation: cardiopulmonary physiology after one year [abstract]. Am J Respir Crit Care Med 1996;133: A637
45. Chan KM, Cohen RG, Barbers RG, et al. Pulmonary function and quality of life following donor lobectomy for lobar lung transplantation [Abstract]. Am J Respir Crit Care Med 1996;153:A657
46. Klineman I, Lowy FH. Ethical consideration in living organ donation and a new approach. Arch Intern Med 1992; 152: 1484-8
47. Spital A. Living related donation: shifting the responsibility. Arch Intern Med 1993;131:234-5
48. Shaw LR, Miller JD, Slutsky AS, et al. Ethics of lung transplantation with live donors. Lancet 1991;338:678-81
49. DeChesser AD. Organ donation: the supply/demand discrepancy. Heart Lung 1986;15:547-51
50. Mannes GP, de Boer WJ, van der Bij W, et al. Patients on the waiting list for lung transplantation in Gronigen: selection and outcome. Nederlands Tijdschrift voor Geneeskunde 1994;138:808-12
51. Sharples L, Belcher C, Dennis C, et al. Who waits longest for heart and lung transplantation? J Heart Lung Transplant 1994;13:282-91
52. Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992;326: 1187-91
53. Ciriaco P, Egan T, Cairns E, et al. Analysis of cystic fibrosis referrals for lungs transplantation. Chest 1995;107: 1323-7
54. Nootens M, Freels S, Kaufmann E, et al. Timing of single lung transplantation for primary pulmonary hypertension. J Heart Lung Transplant 1994;13:276-81
55. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;334:296-302
56. Nootens M, Schrader B, Kaufmann E, et al. Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension. Chest 1995;107:54-7
57. Sitbon O, Brenot F, Denjean A, et al. Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin. Am J Respir Crit Care Med 1995;151:384-9
58. Rubin LJ. ACCP consensus statement on primary pulmonary hypertension. Chest 1993;104:236-50
59. Ries AL. The importance of exercise in pulmonary rehabilitation [Review]. Clin Chest Med 1994;15:327-37
60. Dugan D, Walker R, Monroe DA. The effects of a 9-week program of aerobic and upper body exercise on the maximal voluntary ventilation of chronic obstructive pulmonary disease patients. J Cardpulm Rehabil 1993; 15:130-3
61. Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995;122:823-32
62. Mal H, Sleiman C, Jebrak G, et al Functional results of single-lung transplantation for chronic obstructive lung disease. Am J Respir Crit Care Med 1994;149:1476-81
63. Dromer C, Velly JF, Jougon J, et al. Long-term functional re-sults after bilateral lung transplantation. Ann Thorac Surg 1993;56:68-73
64. Howard DK, Iademarco EJ, Trulock EP. The role of cardiopulmonary exercise testing in lung and heart-lung transplantation [Review]. Clin Chest Med 1994;13:403-20
65. Farge D, Julien J, Amtein C, et al. Effect of systemic hypertension on renal function and left ventricular hypertrophy in heart transplant recipients. J Am Coll Cardiol 1990;15: 1093-1101
66. Scott JP, Higenbottam TW, Hutter JA, et al. Effects of the immunosuppressant cyclosporine on the circulation of heart transplant recipients. Am J Cardiol 1991;67:628-32
67. Hokanson JF, Mercier JG, Brooks GA, Cyclosporine A decreases rat skeletal muscle mitochondrial respiration in vitro. Am J Respir Crit Care Med 1995;151:1848-51
68. Shepard RJ, Bouhlel E, Vandewalle H, et al. Muscle mass as a factor limiting physical work. J Appl Physiol 1988;64: 1472-79
69. de Hoyos AL, Patterson GA, Maurer JR, et al. Pulmonary transplantation: early and late results. J Thorac Cardiovasc Surg 1992;103:293-306
70. Madill J, Maurer JR, de Hoyos A. A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation 1993;56:347-50
71. Howard DK, Iademarco EJ, Trulock EP. The role of cardiopulmonary exercise testing in lung and heart-lung transplantation. Clin Chest Med 1994;15.400-20
72. Hosenpud JD, Novick RJ, Breen TJ, et al. The Registry of the International Society for Heart and Lung Transplantation: twelfth official report - 1995. J Heart Lung Transplant 1995;14:805-13
73. Cooper JD, Pohl MS, Patterson GA. An update on the current status of lung transplantation: report of the St. Louis International Lung Transplant Registry. Clinical Transplants 1993;95-100
74. Scott JP, Higenbottam TW, Sharples L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991;51:813-7
75. Milne DS, Gascoigne AD, Ashcroft T, et al. Organizing pneumonia following pulmonary transplantation and the development of obliterative bronchiolitis. Transplantation 1994;57:1757-62
76. International Society for Heart and Lung Transplantation. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993;12:713-6
77. Rajagopalan N, Maurer J, Kesten S. Bronchodilator response at low lung volumes predicts bronchiolitis obliterans in lung transplant recipients. Chest 1996;109:403-7
78. Zaltzman JS, Pei Y, Maurer J, et al. Cyclosporine nephrotoxicity in lung transplant recipients. Transplantation 1992;54: 873-8
79. Shane E, Schulman L, McGregor C, et al. Osteoporosis in patients awaiting lung transplantation. Am Rev Resp Crit Care Med 1993;151:A91
80. Sambrook PN, Kelly PJ, Keogh AM, et al. Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 1994;13:116-21
81. Epstein S, Shane E, Bilezikian JP. Organ transplantation and osteoporosis [Review]. Curr Opinion Rheum 1993;7: 255-61
82. Sambrook PN, Kelly PJ, Keogh AM, et al. Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant 1994;13:116-21
83. Walker RC, Pava CV, Marshall WF, et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantation. J Heart Lung Transplant 1995;14:214-21
84. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1993;85:332-65
85. Adams DH, Cochrane AD, Khaghani A, et al. Retransplantation in heart-lung recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg 1994;107:450-9
86. Mentzer SJ, Reilly JJ Jr., Caplan AL, et al. Ethical considerations in lung retransplantation. J Heart Lung Transplant 1994;13:56-8
87. Novick RJ, Kave MP, Patterson GA, et al. Redo lung transplantation: a North American-European experience J Heart Lung Transplant 1993;12:5-16
88. Brantigan OC. The surgical treatment of pulmonary emphysema. WV Med 1954;50:283-5
89. Brantigan OC, Mueller EA. Surgical treatment of pulmonary emphysema. Am Surg 1937;23:789-804
90. Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis 1959;80: 194-202
91. Wakabayashi A. Thoracoscopic laser pneumoplasty in the treatment of diffuse bullous emphysema. Ann Thorac Surg 1995;60:936-42
92. Cooper JD, Trulock EP, Triantafillou AN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thor Cardiovasc Surg 1993;109: 106-10
93. Sciurba FC, Rogers RM, Keenan RJ, et al. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med 1996;334: 1095-9
94. Nine JS, Yousem SA, Paradis IL et al. Lymphangioletomy-omatosis. Recurience after lung transplantation. J Heart Lung Transplant 1994;13:714-9
95. Johnson BA, Duncan SR, Ohori NP, et al. Recurience of sarcoidosis in pulmonary allograft recipients Am Rev Respir Dis 1993;148:1373-7
96. Frost AE, Keller CA, Brown RW, et al. Grant cell interstitial pneumonitis. Disease recurience in the transplanted lung. Am Rev Respir Dis 1993;148:1401-4
97. Baz, MA, Kussin PS, Van Trigt P, et al. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med 1995,151.895-8
98. Sobonva RE, Quan SF, Fleishman JS. Pulmonary lymphangioleimyomatosis: quantitative analysis of lesions producing airflow limitation Hum Pathol 1983,16:1122-8
99. Abernathy EC, Hruban RH, Baumgartner WA, et al. The two forms of bronchiolitis obliterans in heart-king transplant recipients. Hum Pathol 1991;22:1102-10
100. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;133: 747-60
101. Scott J, Higenbottam T. Transplantation of the lungs and heart and lung for patients with severe pulmonary complications from sarcoidosis. Sarcoidosis 1990;7:9-11